Clinical Presentations

VCOS 2020 Satellite Symposium: Cardiac MRI in Cardio-Oncology: Strain at its Best Fidelity (MyoStrain®)

October 1, 2020
Virtual Cardio-Oncology Summit 2020
Presented by
Daniel J Lenihan, MD, FACC, FESC
Professor, Division of Cardiovascular Medicine
Director, Cardio-Oncology Center of Excellence
Washington University School of Medicine in St. Louis
President, International Cardio-Oncology Society; Co-chair, V-COS 2020

MyoStrain® plays a critical role in clinical decision-making during the cancer process, particularly in patients at risk of heart failure. Presented at the Virtual Cardio-Oncology Summit on October 1st, 2020, leading cardio-oncology experts discuss how MyoStrain may help to stratify cardiotoxicity risk, optimize cardiovascular therapy, prevent and manage cardiotoxicity, and guide long-term survivors’ follow-up.

Sponsored by Myocardial Solutions, Inc., the Satellite Symposium program addresses the medical community's most frequently asked questions surrounding the use of MyoStrain® for protecting cancer patient heart health, providing practical, case-based examples to demonstrate the potential of MyoStrain® to significantly improve transform cardio-oncology care.

See original content